A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus.
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2014
At a glance
- Drugs Colesevelam (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Daiichi Sankyo Inc
- 10 Jun 2017 Biomarkers information updated
- 01 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Nov 2011 Planned End Date changed from 1 Dec 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.